Hepsera is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Adefovir Dipivoxil.
| Product ID | 61958-0501_565702cd-c843-4c70-bb31-6cb51c170453 | 
| NDC | 61958-0501 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Hepsera | 
| Generic Name | Adefovir Dipivoxil | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2002-09-20 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021449 | 
| Labeler Name | Gilead Sciences, Inc. | 
| Substance Name | ADEFOVIR DIPIVOXIL | 
| Active Ingredient Strength | 10 mg/1 | 
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2002-09-20 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021449 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2002-09-20 | 
| Ingredient | Strength | 
|---|---|
| ADEFOVIR DIPIVOXIL | 10 mg/1 | 
| SPL SET ID: | a60adac4-57c2-4089-aefc-1a77a48676fc | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 46014-0501 | Hepsera | Adefovir Dipivoxil | 
| 61958-0501 | Hepsera | adefovir dipivoxil | 
| 42794-003 | ADEFOVIR DIPIVOXIL | ADEFOVIR DIPIVOXIL | 
| 60505-3947 | Adefovir dipivoxil | adefovir dipivoxil | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  HEPSERA  76275265  2696484 Live/Registered | Gilead Sciences, Inc. 2001-06-19 |